Company intelligence / Profile preview

Nexus Medical and Technology Capital

Quincy, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Globally oriented private equity firm managing funds in Europe and US, focused on early to late-stage medical technology and life science companies. Provides consulting to investment banks on sourcing and evaluating private medical companies. Has made 34 investments, 14 portfolio exits, and 1 acquisition (Selah Genomics in 2013). Portfolio spans medical technology, life sciences, diagnostics (e.g., Selah Genomics, Kiyatec, Spectra Analysis Instruments).

Industry: Investors

Beyond the preview

Go deeper on Nexus Medical and Technology Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nexus Medical and Technology Capital.

Explore the full profile